On August 20, 2024, Kathleen Scott, CFO of ARS Pharmaceuticals Inc, sold 12,500 shares at $16/share. The company focuses on developing health solutions. With a market cap of $1.299 billion, investors can access detailed valuation metrics for financial insights.